Search & Filter

The life chances of many of the 6.5 million people in the UK who care, unpaid, for a disabled, older or ill family member or friend, are being damaged by inadequate support from health services, according to new research launched this week for Carers Week 2016. 

Women diagnosed with migraines have a slightly increased risk of developing cardiovascular diseases, such as heart attacks and strokes, and are more likely to die from these conditions than women who do not have migraine, a large scale study published in The BMJ has revealed.

Women with the most common type of breast cancer could benefit from staying on aromatase inhibitors for a decade, a new study suggests. The study, presented at the American Society of Clinical Oncology (ASCO) conference in Chicago, and published in the New England Journal of Medicine, found that women who took aromatase inhibitors for 10 years rather than five were a third less likely to have their cancer return, or develop cancer in their other breast.

An extended course of hormone therapy after treatment could prevent the recurrence of breast cancer in postmenopausal women with early breast cancer, new data presented at the American Society of Clinical Oncology (ASCO) Annual Meeting has revealed.

Saxenda (liraglutide) could benefit patients with prediabetes and obesity to help them achieve weight loss and improve cardiometabolic risk factors, data from the Phase 3 SCALE (Satiety and Clinical Adiposity €“ Liraglutide Evidence) Obesity and Prediabetes trial has revealed.

The findings of the HOPE-3 trial have the potential to both change and reinforce current clinical practice for primary prevention for patients at intermediate-risk of developing cardiovascular disease. 

The risk of developing aggressive prostate cancer can be worsened by being an unhealthy weight and having a large waistline, a study has found.

Data showed remission and response rates of 37.2% and53.2% respectively at week 12 in refractory ulcerative colitis (UC) patientstreated with Adacolumn

The European Commission (EC) has approved the use of paliperidone palmitate (TREVICTA) €“ a 3-monthly injection €“ for the maintenance treatment of schizophrenia in adult patients.

Data presented at the Digestive Disease Week meeting in San Diego supports the use of Adacolumn in certain patients with moderate-to-severe, steroid-dependent active ulcerative colitis (UC).

An estimated 475,000 hospital admissions were attributed to smoking in 2014-15, a rise of 23,000 (5%) in the past 10 years, according to new figures released by the Health and Social Care Information Centre.

A treatment option for metastatic hormone-relapsed prostate cancer (mHRPC) cabazitaxel (Jevtana) has been recommended for use in combination with prednisone or prednisolone in England following a review by NICE.

Over twice the number of older people than previously thought may be left waiting in hospital despite being ready for discharge, according to a National Audit Office (NAO) report today.

Despite policy pressure on GPs to offer consultations by email or internet video programmes such as Skype, few GPs do and most have no plans to introduce them in future, according to a new study.

NICE has recommended cabazitaxel (Jevtana) for the treatment of metastatic hormone-relapsed prostate cancer (mHRPC) in England, pharma Sanofi Genzyme has announced.